Literature DB >> 8912886

Collagen-induced arthritis in DBA/1 mice: cytokine gene activation following immunization with type II collagen.

L M Stasiuk1, O Abehsira-Amar, C Fournier.   

Abstract

Immunization of DBA/1 mice with bovine type II collagen (CII) in complete Freund's adjuvant (CFA) leads to collagen-induced arthritis as evidenced by joint inflammation. In this study, reverse transcription-polymerase chain reaction (RT-PCR) was used to demonstrate the activation of genes encoding for IL-2, IFN-gamma, and IL-10 in the lymph nodes from both CII-immunized and control CFA-immunized DBA/1 mice, at Days 10, 40, and 70 after immunization, in the absence of any IL-5 or IL-13 transcription. By quantitative RT-PCR, the levels of IFN-gamma mRNA in response to CII could not be quantitatively differentiated from the IFN-gamma transcribed in response to CFA alone. In the joints of CII-immunized mice, IL-1beta and IL-10 mRNA were found in the absence of IL-5 or IFN-gamma. Synovial IL-1beta and IL-10 were expressed most strongly at the time of clinical symptoms, 40 days after immunization. Together, these findings suggest that immunization with CII in CFA induces a type 1 response against the adjuvant, giving a cytokine environment which influences the T cells responding to CII to become type 1 T cells. This is manifested here by the appearance of gene activation in synovial tissue of collagen-immunized mice, but not in adjuvant-immunized control animals.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8912886     DOI: 10.1006/cimm.1996.0277

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  8 in total

1.  JNK1, but not JNK2, is required in two mechanistically distinct models of inflammatory arthritis.

Authors:  Katja Denninger; Susanne Rasmussen; Jeppe Madura Larsen; Catrine Orskov; Steen Seier Poulsen; Poul Sørensen; Jan Pravsgaard Christensen; Harald Illges; Niels Odum; Tord Labuda
Journal:  Am J Pathol       Date:  2011-08-11       Impact factor: 4.307

2.  Evaluation of the anti-arthritic activity of the hydroethanolic leaf extract of Alchornea cordifolia in rats.

Authors:  Adejuwon Adewale Adeneye; Adekunle Ibrahim Oreagba; Ismail Ogunbayode Ishola; Hassanat Adeola Kalejaiye
Journal:  Afr J Tradit Complement Altern Med       Date:  2014-01-28

Review 3.  The genetic and immunopathological processes underlying collagen-induced arthritis.

Authors:  J A Luross; N A Williams
Journal:  Immunology       Date:  2001-08       Impact factor: 7.397

4.  Experimental arthritis in CC chemokine receptor 2-null mice closely mimics severe human rheumatoid arthritis.

Authors:  Marlon P Quinones; Sunil K Ahuja; Fabio Jimenez; Jason Schaefer; Edgar Garavito; Arun Rao; George Chenaux; Robert L Reddick; William A Kuziel; Seema S Ahuja
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

5.  Interleukin-10 produced by B cells is crucial for the suppression of Th17/Th1 responses, induction of T regulatory type 1 cells and reduction of collagen-induced arthritis.

Authors:  Natalie A Carter; Elizabeth C Rosser; Claudia Mauri
Journal:  Arthritis Res Ther       Date:  2012-02-08       Impact factor: 5.156

6.  Prevention of autoimmune disease due to lymphocyte modulation by the B-subunit of Escherichia coli heat-labile enterotoxin.

Authors:  N A Williams; L M Stasiuk; T O Nashar; C M Richards; A K Lang; M J Day; T R Hirst
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

7.  Induction of PNAd and N-acetylglucosamine 6-O-sulfotransferases 1 and 2 in mouse collagen-induced arthritis.

Authors:  Jiwei Yang; Steven D Rosen; Philip Bendele; Stefan Hemmerich
Journal:  BMC Immunol       Date:  2006-06-13       Impact factor: 3.615

8.  20S-Hydroxyvitamin D3, a Secosteroid Produced in Humans, Is Anti-Inflammatory and Inhibits Murine Autoimmune Arthritis.

Authors:  Arnold E Postlethwaite; Robert C Tuckey; Tae-Kang Kim; Wei Li; Syamal K Bhattacharya; Linda K Myers; David D Brand; Andrzej T Slominski
Journal:  Front Immunol       Date:  2021-06-30       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.